These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3360570)

  • 41. Immunomodulation in vitro. The predictive value of in vitro testing of lung cancer patients' lymphocyte responsiveness to stimulation by Thymex L. A preliminary report.
    Vucković-Dekić L; Stanojević-Bakić N; Rajner L; Dekić M; Pesić M
    J Exp Clin Cancer Res; 1997 Sep; 16(3):309-12. PubMed ID: 9387906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer.
    García-Martínez E; Gil GL; Benito AC; González-Billalabeitia E; Conesa MA; García García T; García-Garre E; Vicente V; Ayala de la Peña F
    Breast Cancer Res; 2014 Nov; 16(6):488. PubMed ID: 25432519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cellular immunity & prognosis of human mammary carcinoma.
    Abrol SK; Shinghal RN; Saha K
    Indian J Med Res; 1984 Feb; 79():199-206. PubMed ID: 6611308
    [No Abstract]   [Full Text] [Related]  

  • 44. Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans.
    Hoon DS; Korn EL; Cochran AJ
    Cancer Res; 1987 Mar; 47(6):1740-4. PubMed ID: 3493068
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer].
    Taguchi T
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):387-93. PubMed ID: 6349538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
    Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer.
    Porrata LF; Ingle JN; Litzow MR; Geyer S; Markovic SN
    Bone Marrow Transplant; 2001 Nov; 28(9):865-71. PubMed ID: 11781647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer.
    Knutson KL; Krco CJ; Erskine CL; Goodman K; Kelemen LE; Wettstein PJ; Low PS; Hartmann LC; Kalli KR
    J Clin Oncol; 2006 Sep; 24(26):4254-61. PubMed ID: 16908932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer.
    de Kruijf EM; van Nes JG; Sajet A; Tummers QR; Putter H; Osanto S; Speetjens FM; Smit VT; Liefers GJ; van de Velde CJ; Kuppen PJ
    Clin Cancer Res; 2010 Feb; 16(4):1272-80. PubMed ID: 20145162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival.
    Ladoire S; Mignot G; Dabakuyo S; Arnould L; Apetoh L; Rébé C; Coudert B; Martin F; Bizollon MH; Vanoli A; Coutant C; Fumoleau P; Bonnetain F; Ghiringhelli F
    J Pathol; 2011 Jul; 224(3):389-400. PubMed ID: 21437909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antitumor immunity in breast cancer patients. Biologic and therapeutic implications.
    Black MM; Zachrau RE
    J Reprod Med; 1979 Jul; 23(1):21-32. PubMed ID: 226697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunomodulation by NPT 15392 in cancer patients under chemotherapy.
    Favre R; Bagarry-Liegey D; Jeanroy B; Pignon T; Meyer G; Carcassonne Y
    Adv Exp Med Biol; 1983; 166():261-8. PubMed ID: 6650281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Tolerance and immunocompetence : Ways to repair the immune system in rheumatic inflammation].
    Kneitz C; Radbruch A
    Z Rheumatol; 2024 Mar; 83(2):85-86. PubMed ID: 38416147
    [No Abstract]   [Full Text] [Related]  

  • 56. 'Immunocompetence': conspicuous by its absence.
    Siva-Jothy MT
    Trends Ecol Evol; 1995 May; 10(5):205-6. PubMed ID: 21237008
    [No Abstract]   [Full Text] [Related]  

  • 57. An experimental and clinical study of immunocompetence and immunostimulation in breast cancer.
    Reynier J; Bazin JC; Bizzini B; Villet R; Chany C; Leandri S
    Int Surg; 1988; 73(1):10-5. PubMed ID: 3360570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Carcinoma of the breast. Immune behaviour. Immunostimulation by fraction P40 (author's transl)].
    Reynier J; Bazin JC; Bizzini B; Gandrille C; Guettier C; Henocq E; Hollmann K; Mogenet M; Pompidou A; Santus JP; Verley JM; Villet R
    Chirurgie; 1980 Jan; 106(1):48-55. PubMed ID: 7379633
    [No Abstract]   [Full Text] [Related]  

  • 59. [Breast cancer: a dynamic approach of cellular immunity and immunostimulation with an immunoadjuvant: P40 fraction. (author's transl)].
    Santus JP; Henocq E; Bizzini B; Bazin JC; Mogenet M; Villet R; Reynier J
    Pathol Biol (Paris); 1979 Sep; 27(7):395-401. PubMed ID: 388318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunocompetence, immunosuppression, and human breast cancer. III. Prognostic significance of initial level of immunocompetence in early and advanced disease.
    Adler A; Stein JA; Ben-Efraim S
    Cancer; 1980 Apr; 45(8):2074-83. PubMed ID: 7370953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.